
    
      The total duration of the study per participant was up to 50 or 54 weeks (if accelerated
      elimination procedure performed):

      Screening: up to 2 weeks Teriflunomide treatment: 48 weeks Accelerated elimination procedure:
      4 weeks when performed

      An accelerated elimination procedure at any time after discontinuation of teriflunomide
      treatment was possible and it was particularly recommended for women of child-bearing
      potential.
    
  